충북대학교 의과대학 정형외과학교실, 경기지역 협력연구센터 한경대학교*, 충북대학교 의과대학 생화학교실 † Purpose: Isoflavones are rich in soybean and are known to affect bone formation. This study examined the effects and modes of action of isoflavones on the differentiation of C2C12 myoblasts in the presence of the bone morphogenetic protein (BMP)-4. Materials and Methods: The isoflavones, daidzein, genistein or equol, and/or BMP-4 were added alone or in combination to C2C12 myoblasts. After 72 hours culture, the cells were stained for the early osteoblastic differentiation marker, alkaline phosphatase (ALP). The ALP activity was determined by comparing the color of the stained images as well as by spectrophotometry. The expression profiles of the extracellular matrix (ECM) genes responsible for the extensive remodeling at the cell surface were analyzed using agene expression microarray after treating thesamples with daidzein. Results: ALP staining of BMP-4 or the isoflavones-treated cells showed that BMP-4 increased the activity of ALP in a dose dependent manner, whereas the isoflavones alone did not induced any remarkable increase. However, the ALP activity increased when the cells were treated with BMP-4 and any of the three isoflavones. The macrogen mouse MAC array data showed that the ECM genes, Mmp13 and Mmp3, were up-regulated by daidzein, whereas Col4a2, Col5a1 and Mmp9 were down-regulated. Conclusion: Isoflavones induce osteoblastic differentiation when combined with BMP-4, which is possibly achieved by modulating the expressional levels of various ECM genes.
INTRODUCTION
The role of estrogens and estrogen-like molecules, including isoflavones, in regulating the bone cell activities is essential for understanding the etiology and treatment of post-menopausal osteoporosis. Isoflavonoids, which are found abundant in soybeans, are a group of phytochemicals that show affinity for the estrogen receptor 11, 22) . Iso-flavonoids have been shown to be effective in preventing bone loss in ovariectomized rats and postmenopausal women 17) . Moreover, genistein was found to inhibit the bone loss caused by an estrogen deficiency in mice, and an analogue of coumestrol has been reported to increase the activity of ALP (an osteoblastic phenotype marker) in osteoblast-like cells 9) . These results suggest that isoflavones prevent bone loss and promote bone formation. In addition, it has been reported that isoflavones participate in the apoptosis and differentiations of several cell types 6, 8, 24) . Unlike estrogen, the consumption of isoflavones has been suggested to reduce the risk of breast and prostate cancer 12) .
Phytoestrogens have the potential to maintain bone health and delay or prevent osteoporosis, and several studies have examined the dose-dependent effects on bone and their modes of action 4, 14, 23) . Some reports concluded that the mechanism of action underlying the prevention of bone loss by isoflavones appears to differ from that of estrogen and the selective estrogen receptor modulators 5, 15) . Whilst bothestrogen and raloxifene prevent bone loss by reducing bone resorption, the isoflavones are antiresorptive only at chronic high doses.
Therefore, they have been reported to either inhibit or not affect the bone turnover rate. Moreover, neither estrogen nor raloxifene blocks the elevated bone resorption rates induced by an ovariectomy or menopause 5) . On the other hand, certain isoflavones, including genistein, have been shown to modestly stimulate the osteoblast characteristics, such as, the synthesis of total proteins and mineralized matrix deposition in immature and mature osteoblast cell cultures 26) . Hence, while isoflavone treatment may prevent bone loss, in part, by modulating the balance between bone formation and resorption, the mechanism underlying the enhanced bone formation after an isoflavone treat-ment in vivo is unknown. C2C12 cells were derived from mouse myoblasts, and have the potential to differentiate into osteoblasts. Therefore, they are composed of committed osteoblastic precursor cells 3) . Many studies have examined the conversion of C2C12 cells into an osteoblast lineage when mediated by BMP 2, 10, 27) . It was hypothesized that C2C12 cells might provide useful information about the effects of isoflavones and BMP-4 on osteoblast differentiation. This study examined the in vitro effects of daidzein, genistein, or equol and/or BMP using C2C12 cells to determine the bioactivity of isoflavones in the presence or absence of BMP-4 on the bone metabolism.
MATERIALS AND METHODS

Cell culture and chemicals
The low passage mouse pluripotential mesenchymal precursor line, C2C12, was purchased from 
ALP activity
For the differentiation assays, the C2C12 cells were plated at an initial density of ca. 
Analysis of gene expression using the Illumina mouse MAC array
The total RNA was isolated from a 10 cm template after 96 hours of culture with daidzein. 
3) Effect of equol on C2C12 differentiation
The addition of 5μM to 50μM equol dose-dependently enhanced the ALP staining intensity compared with BMP-4 alone. As was observed with the other two isoflavones, equol alone was ineffective in inducing C2C12 differentiation, as evidenced by the weak blue staining.
4) Quantitative changes in ALP activity
In order to quantify the ALP activity induced by isoflavones, the C2C12 myoblasts were treated separately with the isoflavones or with BMP-4. As shown in Fig. 2 1 to 3 ng/ml)( Fig. 2 ).
Analysis of gene expression using Illumina mouse MAC arrays
This array technique was used to examine the RNA samples from the C2C12 cells treated with daidzein. The genes associated with the ECM glycoproteins, e.g., Leprel1, Nid1, Efemp1 and Ltbp3, were down-regulated, whereas Mfap3 and Fbln1
were up-regulated. The genes associated with the ECM linker proteins, e.g., Lamc1, Lama2, Lama5
were down-regulated. The genes associated with the ECM structural proteins, e.g., Col5a1, Col4a2, Col1a2 and Col8a1 were also down-regulated ( Fig.   3 ). Among the other ECM associated genes, e.g.,
Mmp13 and Mmp3 were up-regulated but Mmp9
and Pcolce2 were down-regulated. . Type IV collagens including Col4a1 are the major components of the basement membrane in blood vessels, and are expressed ubiquitously in the basement membranes during the early developmental stages. Type V collagen (Col5), in addition to types I and XXIV collagens, is known to be a component of mineralized bone and corneal, whereas types II, XI, and XXVII collagen are the components of cartilage 21) . Although these MMPs and collagens are widely perceived to be essential structural and functional components during bone and cartilage development, the contribution of individual gene expression is unclear. Therefore, studies using knock-out mice with single or multiple genes deleted will be needed. Overall, these findings suggest that daidzein may affect osteoblastic differentiation in part by regulating the expression of the ECM associated proteins at the transcription level. However, further study will be needed to determine the mechanism whereby isoflavones affects osteoblast differentiation.
DISCUSSION
CONCLUSION
In summary, results of this study provide evidence that isoflavones weakly induce the expres- 
